The U.S. Food and Drug Administration on Friday approved Teal Health to provide the nation's first at-home test kit to screen for cervical cancer.

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, today announced it has ...

National Jewish Health researchers with the Advanced Diagnostic Laboratories have developed a molecular diagnostic test ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

COPD significantly impairs respiratory function and reduces exercise capacity. Rehabilitation exercises, particularly ...

GSK announced on Thursday that its monoclonal antibody ‘Nucala’, or mepolizumab, delivered a statistically significant and ...

The U.S. Army is set to implement a redesigned fitness test that introduces gender-neutral ... according to a RAND Corporation assessment. The Service Women's Action Network criticized the initial ...

COPD is a progressive condition, which means that it will typically worsen over time. A doctor will monitor your symptoms with a spirometry test, usually once a year, to determine how quickly the ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...